Diabetic Tussin Reintroduces Sugar-Free Cold and Cough Solution for People with Diabetes
Today, Diabetic Tussin®, the trusted cough syrup brand for people with diabetes and prediabetes, announces its sugar-free cold and cough solution is back on shelves. This restock brings with it the Better Choices for Life mark from the American Diabetes…
HeiQ unveils HeiQ Skin Care – a probiotics-infused textile technology
HeiQ introduces a 100% biobased and long-lasting cosmetic finishing technology for textiles to the market. The newest addition to the HeiQ portfolio harnesses the power of active probiotics and selected prebiotics to enhance the skin microbiome, turning the human’s largest organ…
PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence
PostEra, a biotechnology company specializing in artificial intelligence for preclinical drug discovery, today announced a multi-target collaboration with Amgen, a leading biotechnology company. The collaboration will leverage PostEra’s AI platform, Proton, a pioneering innovation in generative chemistry and synthesis-aware design, and…
New Eating Disorder Care Center in Saylorsburg Expands Rural Treatment Options for Adolescents
Blue Ridge Eating Disorder Center, a treatment facility in a homelike setting, promises quality care for our rural community. “Eating disorders don’t discriminate to affecting just those who live in big cities or populated areas, and our staff believe that…
Sigrid Therapeutics Launches the Glucose Stabiliser in the U.S.
Sigrid Therapeutics has launched the Glucose Stabiliser, an over-the-counter blood sugar control supplement that also reduces caloric intake from fats and carbs. With about 1 in every 10 Americans facing a Type 2 diagnosis and the growing popularity of medications used for…
European Wellness and DXN Sign MoU to Establish World-Class Wellness Centre!
European Wellness Biomedical Group (EW Group) has signed a Memorandum of Understanding with DXN Holdings Berhad (DXN) to jointly develop and establish a comprehensive wellness centre that draws from the extensive expertise and experience of both parties. EW Group is…
Clinical Trial Application (IND) for BioRay Pharmaceutical’s BR105 Injection Receives U.S. FDA Approval
BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as “BioRay”) announced on October 7th that its clinical trial application for BR105 Injection has received approval from the United States Food and Drug Administration (FDA). This marks BioRay’s first project to receive FDA IND…
Applied BioMath, LLC Presents Alzheimer’s Disease Research at the 6th Clinical Trials on Alzheimer’s Disease (CTAD)
Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), today announced their participation at the 6th Clinical Trials on Alzheimer’s Disease (CTAD) occurring October 24-27,…
Nibble Health Launches “Simple Bill,” Medical Bill Intelligence for Employees
Nibble Health, a healthcare payments company, today announced the launch of a new medical bill intelligence product called “Simple Bill.” At least 50% of employees in the US defer healthcare because of cost. Nibble Health debuted in late 2022 with…
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) and the Fast…
